Meningitis Investigation Closes Ameridose Until Nov. 5

The owners of a Westborough pharmacy, who also own a Framingham specialty pharmacy linked to the national deadly meningitis outbreak, have agreed to close until Nov. 5, so it can be inspected.

The meningitis outbreak, linked to New England Compounding Center in Framingham, has killed 21 people and infected more than 250 others across America. Lawsuits have been filed against New England Compounding Center in Framingham in 6 states.

Ameridose, which at one point was located in Framingham, but now is located in Westborough agreed to the closure extension with state health officials Friday.

The Massachusetts Board of Registration in Pharmacy told Ameridose  it “finds it necessary to extend the agreement to conduct a comprehensive investigation of facility operations.”

It said the agreement expires on Nov. 5, unless “sooner terminated or later extended by agreement of the parties.”

Today's announcement gives the state more time to complete the investigation.

“We have agreed to this extension in the spirit of full cooperation,” Ameridose said in a written statement.

 “As this extension agreement states, “neither the Board nor the Registrants are aware that any product compounded or produced by the Registrants is in any way unfit for use or consumption.”